Skip to main content

Astra Zeneca 'Far Too Cheap': CIO

Investors should purchase pharmaceuticals shares in firms like Roche, Astra Zeneca, Novartis and GlaxoSmithKline, James Bevan, CIO at CCLA Investment Management, told CNBC Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.